David E. Mosedale
Directeur Technique/Scientifique/R&D chez Methuselah Health UK Ltd.
Profil
David E.
Mosedale was the founder and former Chief Executive Officer of Total Scientific Ltd.
which was founded in 2006.
He is currently a Partner at Total Medical Ventures since 2007 and the Chief Technology Officer at Methuselah Health UK Ltd.
since 2014.
Dr. Mosedale has also held the position of Director at TCP Innovations Ltd.
and Vice President-Research & Development at Pronostics Ltd.
He received his doctorate degree from the University of Cambridge in 1997.
Postes actifs de David E. Mosedale
| Sociétés | Poste | Début |
|---|---|---|
Total Medical Ventures
 Total Medical Ventures Investment ManagersFinance Total Medical Ventures (Total Medical) is a seed and early stage venture capital firm founded in 2001 by David J. Grainger. | Private Equity Investor | 01/02/2007 |
Methuselah Health UK Ltd.
 Methuselah Health UK Ltd. BiotechnologyHealth Technology Methuselah Health UK Ltd. develops platforms for the detection of major diseases for middle and old age people. The company was founded by David John Grainger in 2015 and is headquartered in Babraham, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/11/2014 |
Anciens postes connus de David E. Mosedale
| Sociétés | Poste | Fin |
|---|---|---|
TCP Innovations Ltd.
 TCP Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services TCP Innovations Ltd. provides advices to companies in the life sciences sector in Europe. It specializes in various areas of drug development, including CMC, toxicology, DMPK, and pharmacology. The firm provides back-office services, vivo and vitro services. The company was founded by David J. Grainger in 2001 is headquartered in Babraham, the United Kingdom. | Directeur/Membre du Conseil | - |
Total Scientific Ltd.
 Total Scientific Ltd. Miscellaneous Commercial ServicesCommercial Services Total Scientific Ltd. provides biomarker related research and development services. It provides services to the pharmaceutical, diagnostic, and academic communities. The firm operates as a contract research organization. Its services include biomarker discovery and clinical studies, bio analysis, data management and biostatistics, and in vivo pre-clinical services. The company was founded by David J. Grainger and David E. Mosedale in 2006 and is headquartered in Cambridge, the United Kingdom. | Directeur Général | - |
Pronostics Ltd.
 Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de David E. Mosedale
| University of Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pronostics Ltd.
Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
TCP Innovations Ltd.
TCP Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services TCP Innovations Ltd. provides advices to companies in the life sciences sector in Europe. It specializes in various areas of drug development, including CMC, toxicology, DMPK, and pharmacology. The firm provides back-office services, vivo and vitro services. The company was founded by David J. Grainger in 2001 is headquartered in Babraham, the United Kingdom. | Commercial Services |
Total Medical Ventures
Total Medical Ventures Investment ManagersFinance Total Medical Ventures (Total Medical) is a seed and early stage venture capital firm founded in 2001 by David J. Grainger. | Finance |
Total Scientific Ltd.
Total Scientific Ltd. Miscellaneous Commercial ServicesCommercial Services Total Scientific Ltd. provides biomarker related research and development services. It provides services to the pharmaceutical, diagnostic, and academic communities. The firm operates as a contract research organization. Its services include biomarker discovery and clinical studies, bio analysis, data management and biostatistics, and in vivo pre-clinical services. The company was founded by David J. Grainger and David E. Mosedale in 2006 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Methuselah Health UK Ltd.
Methuselah Health UK Ltd. BiotechnologyHealth Technology Methuselah Health UK Ltd. develops platforms for the detection of major diseases for middle and old age people. The company was founded by David John Grainger in 2015 and is headquartered in Babraham, the United Kingdom. | Health Technology |
